1. Home
  2. GCTK vs ADN Comparison

GCTK vs ADN Comparison

Compare GCTK & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • ADN
  • Stock Information
  • Founded
  • GCTK 2001
  • ADN 2006
  • Country
  • GCTK United States
  • ADN United States
  • Employees
  • GCTK N/A
  • ADN N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • ADN Power Generation
  • Sector
  • GCTK Health Care
  • ADN Utilities
  • Exchange
  • GCTK Nasdaq
  • ADN Nasdaq
  • Market Cap
  • GCTK 7.1M
  • ADN 8.5M
  • IPO Year
  • GCTK N/A
  • ADN N/A
  • Fundamental
  • Price
  • GCTK $2.17
  • ADN $1.75
  • Analyst Decision
  • GCTK
  • ADN
  • Analyst Count
  • GCTK 0
  • ADN 0
  • Target Price
  • GCTK N/A
  • ADN N/A
  • AVG Volume (30 Days)
  • GCTK 10.0K
  • ADN 31.5K
  • Earning Date
  • GCTK 11-02-2024
  • ADN 10-15-2024
  • Dividend Yield
  • GCTK N/A
  • ADN N/A
  • EPS Growth
  • GCTK N/A
  • ADN N/A
  • EPS
  • GCTK N/A
  • ADN N/A
  • Revenue
  • GCTK N/A
  • ADN $7,026,000.00
  • Revenue This Year
  • GCTK N/A
  • ADN $2,232.99
  • Revenue Next Year
  • GCTK N/A
  • ADN $91.56
  • P/E Ratio
  • GCTK N/A
  • ADN N/A
  • Revenue Growth
  • GCTK N/A
  • ADN 9.01
  • 52 Week Low
  • GCTK $0.67
  • ADN $1.71
  • 52 Week High
  • GCTK $4.95
  • ADN $18.90
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 41.99
  • ADN 37.69
  • Support Level
  • GCTK $2.11
  • ADN $1.79
  • Resistance Level
  • GCTK $2.29
  • ADN $1.99
  • Average True Range (ATR)
  • GCTK 0.10
  • ADN 0.17
  • MACD
  • GCTK -0.02
  • ADN 0.01
  • Stochastic Oscillator
  • GCTK 50.49
  • ADN 7.02

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

Share on Social Networks: